FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Keep Device Real-World Evidence Under NESTcc: MDMA

Medical Device Manufacturers Association says it would be wasteful and duplicative to use medical device user fee funds to advance real-world data/evi...

latest-news-card-1
Human Drugs

Athenex Cell Therapy on Clinical Hold

FDA issues a clinical hold against Athenex and Baylor College of Medicines kUR-501 after the death of a young heavily pretreated male patient.

latest-news-card-1
Medical Devices

Remote Assessments May Be Model for Device Inspections

Former CDRH Office of Compliance director Steven Silverman recommends device manufacturers look at FDAs remote regulatory assessment program as a temp...

latest-news-card-1
Human Drugs

Accelerated Approval Mulled for Biogens Tofersen

FDA reviewers appear open to considering accelerated approval for Biogens amyotrophic lateral sclerosis drug tofersen in patients with the superoxide ...

latest-news-card-1
Federal Register

Guide on Clinical Trial Electronic Records

Federal Register notice: FDA makes available a draft guidance entitled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical I...

latest-news-card-1
Human Drugs

Ipsen NDA Resubmission for Palovarotene

FDA accepts for review an Ipsen resubmitted NDA for palovarotene as a potential treatment for fibrodysplasia ossificans progressive.

latest-news-card-1
Biologics

Sarepta BLA Needs Panel Review: FDA

FDA tells Sarepta Therapeutics that it has decided to hold an advisory committee meeting to review its gene therapy BLA for SRP-9001 (delandistrogene ...

latest-news-card-1
Federal Register

Guide on Pharmacogenomic Data Submissions

FDA posts a draft guidance entitled Pharmacogenomic Data Submissions that discusses the use of such data in drug development.

latest-news-card-1
Federal Register

CDER Regulatory Site Tours Continue

Federal Register notice: CDER announces the continuation of its Regulatory Project Management Site Tours and Regulatory Interaction Program.

latest-news-card-1
Medical Devices

FDA Hits Olympus with Warning Letter

FDA issues Olympus Medical Systems a Warning Letter after inspecting the firms Tokyo facility and documenting GMP deficiencies.